Welcome!

News Feed Item

Spasticity Global Clinical Trials Review, H2, 2014

LONDON, Aug. 11, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:

Spasticity Global Clinical Trials Review, H2, 2014

https://www.reportbuyer.com/product/2280943/Spasticity-Global-Clinical-Trials-Review-H2-2014.html

Spasticity Global Clinical Trials Review, H2, 2014

Summary

GlobalData's clinical trial report, "Spasticity Global Clinical Trials Review, H2, 2014" provides data on the Spasticity clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Spasticity. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Spasticity. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Spasticity 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Spasticity to Central Nervous System Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Spasticity to Central Nervous System Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Spasticity 25
Subjects Recruited Over a Period of Time 27
Clinical Trials by Sponsor Type 28
Prominent Sponsors 29
Top Companies Participating in Spasticity Therapeutics Clinical Trials 30
Prominent Drugs 32
Clinical Trial Profiles 33
Clinical Trial Overview of Top Companies 33
Allergan, Inc. 33
Clinical Trial Overview of Allergan, Inc. 33
Ipsen S.A. 35
Clinical Trial Overview of Ipsen S.A. 35
Merz Pharma GmbH & Co. KgaA 36
Clinical Trial Overview of Merz Pharma GmbH & Co. KgaA 36
GW Pharmaceuticals plc 37
Clinical Trial Overview of GW Pharmaceuticals plc 37
GlaxoSmithKline plc 38
Clinical Trial Overview of GlaxoSmithKline plc 38
Sun Pharma Advanced Research Company 39
Clinical Trial Overview of Sun Pharma Advanced Research Company 39
MediciNova, Inc. 40
Clinical Trial Overview of MediciNova, Inc. 40
Acorda Therapeutics, Inc. 41
Clinical Trial Overview of Acorda Therapeutics, Inc. 41
Concert Pharmaceuticals, Inc. 42
Clinical Trial Overview of Concert Pharmaceuticals, Inc. 42
Almirall, S.A. 43
Clinical Trial Overview of Almirall, S.A. 43
Clinical Trial Overview of Top Institutes / Government 44
Vanderbilt University 44
Clinical Trial Overview of Vanderbilt University 44
National Institute of Neurological Disorders and Stroke 45
Clinical Trial Overview of National Institute of Neurological Disorders and Stroke 45
University of Minnesota 46
Clinical Trial Overview of University of Minnesota 46
University of Alberta 47
Clinical Trial Overview of University of Alberta 47
Eunice Kennedy Shriver National Institute of Child Health and Human Development 48
Clinical Trial Overview of Eunice Kennedy Shriver National Institute of Child Health and Human Development 48
University of Manitoba 49
Clinical Trial Overview of University of Manitoba 49
Princess Margaret Hospital 50
Clinical Trial Overview of Princess Margaret Hospital 50
Center for Medicinal Cannabis Research 51
Clinical Trial Overview of Center for Medicinal Cannabis Research 51
Department of Health, UK 52
Clinical Trial Overview of Department of Health, UK 52
University Hospital of Mont-Godinne 53
Clinical Trial Overview of University Hospital of Mont-Godinne 53
Five Key Clinical Profiles 54
Appendix 117
Abbreviations 117
Definitions 117
Research Methodology 118
Secondary Research 118
About GlobalData 119
Contact Us 119
Disclaimer 119
Source 119

List of Tables

Spasticity Therapeutics, Global, Clinical Trials by Region, 2014* 7
Spasticity Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Spasticity Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Spasticity Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 10
Spasticity Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11
Spasticity Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Spasticity Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014* 13
Spasticity Therapeutics Clinical Trials, Central and South America, Top Countries, 2014* 14
Proportion of Spasticity to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 15
Spasticity Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Spasticity Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Spasticity to Central Nervous System Clinical Trials, E7 Countries (%), 2014* 18
Spasticity Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Spasticity Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Spasticity Therapeutics, Global, Clinical Trials by Phase, 2014* 21
Spasticity Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 22
Spasticity Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Spasticity Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Spasticity Therapeutics, Global, Withdrawn Clinical Trials, 2014* 25
Spasticity Therapeutics, Global, Terminated Clinical Trials, 2014* 26
Spasticity Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 27
Spasticity Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 28
Spasticity Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 29
Spasticity Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 31
Spasticity Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 32
Spasticity Therapeutics Clinical Trials Market, Global, Clinical Trials by Allergan, Inc., 2014* 33
Spasticity Therapeutics Clinical Trials Market, Global, Clinical Trials by Ipsen S.A., 2014* 35
Spasticity Therapeutics Clinical Trials Market, Global, Clinical Trials by Merz Pharma GmbH & Co. KgaA, 2014* 36
Spasticity Therapeutics Clinical Trials Market, Global, Clinical Trials by GW Pharmaceuticals plc, 2014* 37
Spasticity Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2014* 38
Spasticity Therapeutics Clinical Trials Market, Global, Clinical Trials by Sun Pharma Advanced Research Company, 2014* 39
Spasticity Therapeutics Clinical Trials Market, Global, Clinical Trials by MediciNova, Inc., 2014* 40
Spasticity Therapeutics Clinical Trials Market, Global, Clinical Trials by Acorda Therapeutics, Inc., 2014* 41
Spasticity Therapeutics Clinical Trials Market, Global, Clinical Trials by Concert Pharmaceuticals, Inc., 2014* 42
Spasticity Therapeutics Clinical Trials Market, Global, Clinical Trials by Almirall, S.A., 2014* 43
Spasticity Therapeutics Clinical Trials Market, Global, Clinical Trials by Vanderbilt University, 2014* 44
Spasticity Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institute of Neurological Disorders and Stroke, 2014* 45
Spasticity Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Minnesota, 2014* 46
Spasticity Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Alberta, 2014* 47
Spasticity Therapeutics Clinical Trials Market, Global, Clinical Trials by Eunice Kennedy Shriver National Institute of Child Health and Human Development, 2014* 48
Spasticity Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Manitoba, 2014* 49
Spasticity Therapeutics Clinical Trials Market, Global, Clinical Trials by Princess Margaret Hospital, 2014* 50
Spasticity Therapeutics Clinical Trials Market, Global, Clinical Trials by Center for Medicinal Cannabis Research, 2014* 51
Spasticity Therapeutics Clinical Trials Market, Global, Clinical Trials by Department of Health, UK, 2014* 52
Spasticity Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital of Mont-Godinne, 2014* 53

List of Figures

Spasticity Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Spasticity Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Spasticity Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Spasticity Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014* 10
Spasticity Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11
Spasticity Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
Spasticity Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2014* 13
Spasticity Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2014* 14
Proportion of Spasticity to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 15
Spasticity Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Spasticity Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Spasticity to Central Nervous System Clinical Trials, E7 Countries (%), 2014* 18
Spasticity Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Spasticity Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Spasticity Therapeutics, Global, Clinical Trials by Phase (%), 2014* 21
Spasticity Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 22
Spasticity Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Spasticity Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Spasticity Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 27
Spasticity Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 28
Spasticity Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 29
Spasticity Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 30
Spasticity Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 32
GlobalData Methodology 118


Read the full report:
Spasticity Global Clinical Trials Review, H2, 2014

https://www.reportbuyer.com/product/2280943/Spasticity-Global-Clinical-Trials-Review-H2-2014.html

For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: [email protected]
Tel: +44 208 816 85 48
Website: www.reportbuyer.com

 

SOURCE ReportBuyer

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
SYS-CON Events announced today that EARP Integration will exhibit at SYS-CON's 20th International Cloud Expo®, which will take place on June 6-8, 2017, at the Javits Center in New York City, NY. EARP Integration is a passionate software house. Since its inception in 2009 the company successfully delivers smart solutions for cities and factories that start their digital transformation. EARP provides bespoke solutions like, for example, advanced enterprise portals, business intelligence systems an...
IBM helps FinTechs and financial services companies build and monetize cognitive-enabled financial services apps quickly and at scale. Hosted on IBM Bluemix, IBM’s platform builds in customer insights, regulatory compliance analytics and security to help reduce development time and testing. In his session at 20th Cloud Expo, Tom Eck, Industry Platforms CTO at IBM Cloud, will discuss how these tools simplify the time-consuming tasks of selection, mapping and data integration, allowing developers ...
Regardless of what business you’re in, it’s increasingly a software-driven business. Consumers’ rising expectations for connected digital and physical experiences are driving what some are calling the "Customer Experience Challenge.” In his session at @DevOpsSummit at 20th Cloud Expo, Marco Morales, Director of Global Solutions at CollabNet, will discuss how organizations are increasingly adopting a discipline of Value Stream Mapping to ensure that the software they are producing is poised to o...
SYS-CON Events announced today that Outscale, a global pure play Infrastructure as a Service provider and strategic partner of Dassault Systèmes, will exhibit at SYS-CON's 20th International Cloud Expo®, which will take place on June 6-8, 2017, at the Javits Center in New York City, NY. Founded in 2010, Outscale simplifies infrastructure complexities and boosts the business agility of its customers. Outscale delivers a secure, reliable and industrial strength solution for its customers, which in...
SYS-CON Events announced today that Progress, a global leader in application development, has been named “Bronze Sponsor” of SYS-CON's 20th International Cloud Expo®, which will take place on June 6-8, 2017, at the Javits Center in New York City, NY. Enterprises today are rapidly adopting the cloud, while continuing to retain business-critical/sensitive data inside the firewall. This is creating two separate data silos – one inside the firewall and the other outside the firewall. Cloud ISVs oft...
Interested in leveling up on your Cloud Foundry skills? Join IBM for Cloud Foundry Days on June 7 at Cloud Expo New York at the Javits Center in New York City. Cloud Foundry Days is a free half day educational conference and networking event. Come find out why Cloud Foundry is the industry's fastest-growing and most adopted cloud application platform.
In order to meet the rapidly changing demands of today’s customers, companies are continually forced to redefine their business strategies in order to meet these needs, stay relevant and continue to see profitable growth. IoT deployment and development is integral in this transformation, and today businesses are increasingly seeing the value of investing their resources into IoT deployments. These technologies are able increase ROI through projects such as connecting supply chains or enabling sm...
Most DevOps journeys involve several phases of maturity. Research shows that the inflection point where organizations begin to see maximum value is when they implement tight integration deploying their code to their infrastructure. Success at this level is the last barrier to at-will deployment. Storage, for instance, is more capable than where we read and write data. In his session at @DevOpsSummit at 20th Cloud Expo, Josh Atwell, a Developer Advocate for NetApp, will discuss the role and value...
As cloud adoption continues to transform business, today's global enterprises are challenged with managing a growing amount of information living outside of the data center. The rapid adoption of IoT and increasingly mobile workforce are exacerbating the problem. Ensuring secure data sharing and efficient backup poses capacity and bandwidth considerations as well as policy and regulatory compliance issues.
SYS-CON Events announced today that Cloud Academy will exhibit at SYS-CON's 20th International Cloud Expo®, which will take place on June 6-8, 2017, at the Javits Center in New York City, NY. Cloud Academy is the industry’s most innovative, vendor-neutral cloud technology training platform. Cloud Academy provides continuous learning solutions for individuals and enterprise teams for Amazon Web Services, Microsoft Azure, Google Cloud Platform, and the most popular cloud computing technologies. Ge...
When NSA's digital armory was leaked, it was only a matter of time before the code was morphed into a ransom seeking worm. This talk, designed for C-level attendees, demonstrates a Live Hack of a virtual environment to show the ease in which any average user can leverage these tools and infiltrate their network environment. This session will include an overview of the Shadbrokers NSA leak situation.
SYS-CON Events announced today that delaPlex will exhibit at SYS-CON's @ThingsExpo, which will take place on June 6-8, 2017, at the Javits Center in New York City, NY. delaPlex pioneered Software Development as a Service (SDaaS), which provides scalable resources to build, test, and deploy software. It’s a fast and more reliable way to develop a new product or expand your in-house team.
In his opening keynote at 20th Cloud Expo, Michael Maximilien, Research Scientist, Architect, and Engineer at IBM, will motivate why realizing the full potential of the cloud and social data requires artificial intelligence. By mixing Cloud Foundry and the rich set of Watson services, IBM's Bluemix is the best cloud operating system for enterprises today, providing rapid development and deployment of applications that can take advantage of the rich catalog of Watson services to help drive insigh...
SYS-CON Events announced today that Interoute has been named “Bronze Sponsor” of SYS-CON's 20th International Cloud Expo®, which will take place on June 6-8, 2017, at the Javits Center in New York City, NY. Interoute is the owner operator of Europe's largest network and a global cloud services platform, which encompasses over 70,000 km of lit fiber, 15 data centers, 17 virtual data centers and 33 colocation centers, with connections to 195 additional partner data centers. Our full-service Unifie...
Amazon started as an online bookseller 20 years ago. Since then, it has evolved into a technology juggernaut that has disrupted multiple markets and industries and touches many aspects of our lives. It is a relentless technology and business model innovator driving disruption throughout numerous ecosystems. Amazon’s AWS revenues alone are approaching $16B a year making it one of the largest IT companies in the world. With dominant offerings in Cloud, IoT, eCommerce, Big Data, AI, Digital Assis...